Delineation of the minimal region of loss at 13q14 in multiple myeloma

被引:57
作者
Elnenaei, MO
Hamoudi, RA
Swansbury, J
Gruszka-Westwood, AM
Brito-Babapulle, V
Matutes, E
Catovsky, D
机构
[1] Royal Marsden Hosp Trust, Acad Dept Haematol & Cytogenet, London SW3 6JJ, England
[2] Inst Canc Res, Dept Acad Haematol & Cytogenet, London SW3 6JB, England
关键词
D O I
10.1002/gcc.10140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have focused on the incidence and prognostic implications of 13q14 deletions in multiple myeloma (MM), but none has sought to delineate the minimal common deleted region (CDR). In an effort to do so, dual-color interphase fluorescence in situ hybridization (FISH) was applied on 82 myeloma cases, initially by use of three probes for 13q14 (RBI, D13S319, and DIMS). Deletions were detected in 29/82 (35.4%) cases, and all except one were monoallelic. Subsequently, contiguous YACs, PACs, and a BAC spanning the 13q14-q21 region were employed for deletion mapping in addition to a 13q telomere probe. Large deletions extending to the 13q34 region were found in 55% of the deleted cases, whereas an additional 13.8% showed loss of both 13q34 and 13q 14 regions with retention of 13q21. A CDR of approximately 350 kb was identified at 13q 14 with the proximal border approximately 120 kb centromeric from D13S319, encompassing an area rich in expressed sequence tagged sites and containing DLEU1, DLEU2, and RFP2 genes. Direct sequencing of the RFP2 gene revealed no mutations in six patients and four MM cell lines harboring deletions of the CDR. However, a role for RFP2 in the pathogenesis of MM cannot yet be excluded, given that alternative mechanisms such as haploinsufficiency remain possible. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:99 / 106
页数:8
相关论文
共 36 条
[1]  
Avet-Loiseau H, 1999, CANCER RES, V59, P4546
[2]   Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13 [J].
Avet-Loiseau, H ;
Daviet, A ;
Saunier, S ;
Bataille, R .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1116-1117
[3]   Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma [J].
Bergsagel, PL ;
Chesi, M ;
Nardini, E ;
Brents, LA ;
Kirby, SL ;
Kuehl, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :13931-13936
[4]   Assignment of 48 ESTs to chromosome 13 band q14.3 and expression pattern for ESTs located in the core region deleted in B-CLL [J].
Bézieau, S ;
Devilder, MC ;
Rondeau, G ;
Cadoret, E ;
Moisan, JP ;
Moreau, I .
GENOMICS, 1998, 52 (03) :369-373
[5]   Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3 [J].
BouygeMoreau, I ;
Rondeau, G ;
AvetLoiseau, H ;
Andre, MT ;
Bezieau, S ;
Cherel, M ;
Saleun, S ;
Cadoret, E ;
Shaikh, T ;
DeAngelis, MM ;
Arcot, S ;
Batzer, M ;
Moisan, JP ;
Devilder, MC .
GENOMICS, 1997, 46 (02) :183-190
[6]   Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia [J].
Bullrich, F ;
Veronese, ML ;
Kitada, S ;
Jurlander, J ;
Caligiuri, MA ;
Reed, JC ;
Croce, CM .
BLOOD, 1996, 88 (08) :3109-3115
[7]  
Calasanz MJ, 1997, GENE CHROMOSOME CANC, V18, P84, DOI 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.3.CO
[8]  
2-9
[9]   Frequent monoallelic loss of D13S319 in multiple myeloma patients shown by interphase fluorescence in situ hybridization [J].
Chang, H ;
Bouman, D ;
Boerkoel, CF ;
Stewart, AK ;
Squire, JA .
LEUKEMIA, 1999, 13 (01) :105-109
[10]   CYTOGENETIC DATA IN 41 PATIENTS WITH MULTIPLE-MYELOMA - KARYOTYPE AND OTHER CLINICAL-PARAMETERS [J].
CIGUDOSA, JC ;
CALASANZ, MJ ;
ODERO, MD ;
PROSPER, F ;
ETXANIZ, A ;
MARIN, J ;
RIFON, J ;
GULLON, A ;
ROCHA, E .
CANCER GENETICS AND CYTOGENETICS, 1994, 78 (02) :210-213